Research News and Research

RSS

Intarcia's ITCA 650 phase 2 study in type 2 diabetes begins patient enrollment

Intarcia Therapeutics, Inc. today announced the start of enrollment for a phase 2 study comparing its proprietary drug candidate ITCA 650 (DUROS continuous delivery of exenatide) with Byetta, an FDA-approved twice-daily injection form of exenatide.

17 Sep 2009

Workshop to address high-risk adolescent behaviors

The Evolution Institute and the University of Arizona's Frances McClelland Institute for Children, Youth, and Families are co-hosting an invitation-only workshop at the university, Oct. 30 - Nov. 2, for world-renowned scholars who will apply evolutionary theory to the development of practical solutions for high-risk adolescent behaviors plaguing Western societies.

17 Sep 2009

LAB Research signs exclusive agreement to extend Korean market

LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has extended its Korean market coverage through a new exclusive agency agreement with Safe Chemicals Co., LTD., a South Korea based consulting company ("Safe Chemicals").

17 Sep 2009

Study: HBV genotype is not linked to hepatocellular carcinoma

Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial. It is likely that this depends on the HBV genotype distribution in certain region.

17 Sep 2009

First Edition: September 17, 2009

Today's headlines focus on two clear story lines: First, the long-awaited and much-anticipated Baucus health overhaul measure was unveiled yesterday; second, it's reception was only lukewarm.

17 Sep 2009

Congresswoman Eshoo honored with The Science Coalition's Champion of Science Award

The Science Coalition today gave Congresswoman Anna Eshoo its "Champion of Science" award in recognition of her strong commitment and continued advocacy for basic research funding. "Representing much of Silicon Valley and several research institutions, Congresswoman Eshoo understands the significant role basic research plays both in advancing our knowledge in critical areas like health care and energy and in driving our economy," said Dr. Philip Pizzo, Dean, Stanford School of Medicine.

17 Sep 2009

Hypatia Research on the benefits of electronic health records systems

Hypatia Research, LLC today released a report entitled "What Healthcare CIOs Need to Know About ARRA & EHR: Healthcare Technology Solutions & Service Providers" outlining current developments, major adoption challenges, business case justification and an assessment of more than 30 EHR vendors that meet government standards for certification and funding programs.

17 Sep 2009

PIPC supports new comparative effectiveness research proposal

The Partnership to Improve Patient Care (PIPC), a non-partisan, patient- focused, grassroots organization focused on securing patient-centered comparative effectiveness research (CER) voiced its strong support of the comparative effectiveness research provisions in Senate Finance Committee Chairman Max Baucus’s health reform proposal released today.

17 Sep 2009

GENova Biotherapeutics signs collaboration deal with Beckpharma

GENova Biotherapeutics Inc. ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has signed a collaboration deal with Beckpharma Ltd.

17 Sep 2009

Discovery of key molecule may yield new therapies for AIDS and cancer

Discovery by Hebrew University of Jerusalem researchers of an additional role for a key molecule in our bodies provides a further step in world-wide efforts to develop genetic regulation aimed at controlling many diseases, including AIDS and various types of cancers.

17 Sep 2009

Laerdal Medical redeveloping its Emergency Preparedness Scenarios simulation packages

Laerdal Medical, in conjunction with The University of Miami's Gordon Center for Research in Medical Education, is in the final stages of re-developing the Emergency Preparedness Scenarios - Terrorism package to function on Laerdal's VitalSim-capable Simulators.

From Laerdal 17 Sep 2009

Pervasis Therapeutics raises funds to support clinical development programs

Pervasis Therapeutics, Inc. today announced that it completed the initial closing of a $17 million third round of financing. The proceeds will be used primarily to support the company's ongoing clinical development programs, including PVS-10200, a biologically active therapy designed to reestablish healthy vasculature following common interventions to treat peripheral arterial disease (PAD) and potentially other conditions.

17 Sep 2009

National Institute for Health Research funds for wound care research

The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.

17 Sep 2009

NIH to fund grants for epigenetic research

The National Institutes of Health announced today that it will fund 22 grants on genome-wide studies of how epigenetic changes -- chemical modifications to genes that result from diet, aging, stress, or environmental exposures -- define and contribute to specific human diseases and biological processes.

17 Sep 2009

Helicos Biosciences to raise $10 million through private placement

Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets, today announced that it has entered into a definitive agreement with certain new and existing investors, including Atlas Ventures, Flagship Ventures, Highland Capital Partners, Versant Ventures (the “Existing Investors”) and Ron Lowy, the Company’s chief executive officer, to raise approximately $10 million in gross proceeds in a private placement through the sale of shares of its common stock and warrants.

17 Sep 2009

Cepacol introduces instant pain relief tablets for children with sore throats

As a leader in the Lozenge Category, Cepacol(R) has announced the introduction of Cepacol(R) Fizzlers(TM), a single symptom sore throat relief product designed specifically for kids.

17 Sep 2009

Biomagnetics and U.S. Government laboratory continue contract negotiations

Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company is in continuing contract negotiations to acquire the rights to Integrated Optical Biosensor System (IBOS) technology developed by one of the U.S. Government’s top national security research institutions.

17 Sep 2009

Canadian Prime Minister's silence is frustrating and disheartening, says Canadian Health Coalition

Canadians are "frustrated and disheartened" by Prime Minister Stephen Harper's silence in the face of attacks on Canada's public health care system, says Michael McBane, National Coordinator of the Canadian Health Coalition. The healthcare group is calling on the Prime Minister to show Canadians where he stands on keeping Canada's health care system public.

17 Sep 2009

Research study on Lyme disease

Potentially debilitating Lyme disease doesn't afflict people everywhere that the ticks harboring it are found. At least not yet. A five-university consortium led by a Michigan State University researcher wants to find out why.

17 Sep 2009

New legislation protects healthcare coverage for rare disease clinical trial participants

Four members of the United States Senate introduced legislation today to allow patients with rare diseases to participate in clinical drug studies without losing their eligibility for public healthcare coverage, echoing a move by the House of Representatives last month.

17 Sep 2009